Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Managing acute myeloid leukaemia during the COVID-19 pandemic

Dr Naval Daver - MD Anderson Cancer Center, Houston, USA

Managing acute myeloid leukaemia during the COVID-19 pandemic ( Dr Naval Daver - MD Anderson Cancer Center, Houston, USA )

Meet the Expert: Daniel Seymour

Daniel Seymour - BIO Ventures for Global Health, Seattle, USA

Meet the Expert: Daniel Seymour ( Daniel Seymour - BIO Ventures for Global Health, Seattle, USA )

Gut microbiome disturbance by antibiotic treatment early in life is sufficient...

Dr Carolina Vicente-Dueñas - Institute of Biomedical Research of Salamanca...

Gut microbiome disturbance by antibiotic treatment early in life is sufficient to induce leukaemia in predisposed mice ( Dr Carolina Vicente-Dueñas - Institute of Biomedical Research of Salamanca, Salamanca, Spain )

COMBI-AD trial: Adjuvant dabrafenib plus trametinib in patients with resected...

Prof Axel Hauschild - University Hospital, Schleswig-Holstein, Germany

COMBI-AD trial: Adjuvant dabrafenib plus trametinib in patients with resected stage III BRAF V600–mutant melanoma ( Prof Axel Hauschild - University Hospital, Schleswig-Holstein, Germany )

Safety and efficacy of CD19/CD22 CAR T cells in children and young adults with...

Dr Haneen Shalabi - National Cancer Institute, NIH, Bethesda, USA

$Safety and efficacy of CD19/CD22 CAR T cells in children and young adults with relapsed/refractory ALL ( Dr Haneen Shalabi - National Cancer Institute, NIH, Bethesda, USA )$

Medical oncology care amidst the COVID-19 pandemic at the National University...

Dr Marvin Mendoza - University of the Philippines - Philippine General Hospital...

Medical oncology care amidst the COVID-19 pandemic at the National University Hospital in the Philippines ( Dr Marvin Mendoza - University of the Philippines - Philippine General Hospital, Manila, Philippines )

Using the novel antibody-drug conjugate, loncastuximab tesirine to treat...

Prof Carmelo Carlo-Stella - Humanitas Cancer Center, Milan, Italy

Using the novel antibody-drug conjugate, loncastuximab tesirine to treat patients with R/R diffuse large B-cell lymphoma ( Prof Carmelo Carlo-Stella - Humanitas Cancer Center, Milan, Italy )

Treating patients with multiple myeloma in the real world

Dr Ajai Chari and Prof Roman Hájek

Treating patients with multiple myeloma in the real world ( Dr Ajai Chari and Prof Roman Hájek )

ASCEND final results: Acalabrutinib vs idelalisib plus rituximab or...

Prof Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy

ASCEND final results: Acalabrutinib vs idelalisib plus rituximab or bendamustine plus rituximab in R/R CLL ( Prof Paolo Ghia - Vita-Salute San Raffaele University, Milan, Italy )

KarMMa: Idecabtagene vicleucel in patients with r/r multiple myeloma

Prof Jesús San Miguel - Universidad de Navarra, Pamplona, Spain

KarMMa: Idecabtagene vicleucel in patients with r/r multiple myeloma ( Prof Jesús San Miguel - Universidad de Navarra, Pamplona, Spain )

Combining the novel anti-CD47 antibody magrolimab with azacitidine in patients...

Dr Naval Daver - MD Anderson Cancer Center, Houston, USA

Combining the novel anti-CD47 antibody magrolimab with azacitidine in patients with TP53-mutant AML ( Dr Naval Daver - MD Anderson Cancer Center, Houston, USA )

New CAR T therapy for relapsed and refractory ALL

Dr Claire Roddie - University College London, London, UK

$New CAR T therapy for relapsed and refractory ALL ( Dr Claire Roddie - University College London, London, UK )$

More from ecancer